Buy, hold, sell: CSL, Lynas, and Wesfarmers shares

Should you buy these giants? Here's what Bell Potter thinks.

There are a lot of ASX shares for investors to choose from on the Australian share market.

To narrow things down, let's see what analysts at Bell Potter are saying about the three popular shares listed below, courtesy of The Bull. Here's what you need to know:

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer

Image source: Getty Images

CSL Ltd (ASX: CSL)

Despite trading on lower than normal multiples and having an attractive longer term product pipeline, the team at Bell Potter still only rates CSL shares as a hold this week. Following the biotech giant's half-year results, the broker said:

 This plasma and vaccines giant reported revenue of $US8.3 billion in the first half of 2026, down 4 per cent on the prior corresponding period. Underlying net profit after tax and amortisation (NPATA) of $US1.9 billion, excluding restructuring costs and impairments, was down 7 per cent. The company has maintained full year guidance, with revenue forecast to increase between 2 per cent and 3 per cent and NPATA between 4 per cent and 7 per cent at constant currency. CSL trades below its historical price/earnings ratio and peers. Longer term product pipelines remain attractive.

Lynas Rare Earths Ltd (ASX: LYC)

Bell Potter has named this ASX rare earths stock as a sell this week. It believes the company's shares are expensive (and volatile). And with execution risks remaining elevated, the broker thinks investors should keep their powder dry for the time being. It said:

While Lynas boasts strategic positioning in rare earths amid a positive long term theme, execution risks, in our view, remain elevated. The consensus among market watchers is for significant volatility ahead. Operational challenges, including power supply disruptions at the Kalgoorlie processing plant and geopolitical uncertainty, add further complexity. The share price has been volatile. It rose from $6.89 on February 12, 2025 to $21.64 on October 15. LYC was trading at $15.92 on February 12, 2026. There's no dividend yield.

Wesfarmers Ltd (ASX: WES)

Finally, Bell Potter has put a hold rating on Wesfarmers shares ahead of its half-year results.

The broker sees potential for a strong result to be a positive catalyst for its shares, but with a stretched valuation, it thinks investors should be waiting for a better entry point. It said:

The industrial conglomerate's interim results for fiscal year 2026 are scheduled to be released on February 19. The results could serve as a positive catalyst, with growth most likely led by Bunnings and Kmart Group. Wesfarmers posted statutory net profit after tax of $2.926 billion in full year 2025, an increase of 14.4 per cent on the prior corresponding period.

While its valuation remains stretched, operating momentum and productivity investments in digital and supply chain capabilities support earnings resilience. Capital management initiatives — such as a payout of $3.56 a share that includes special distributions — further enhances total return. The current valuation leaves a hold recommendation.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Wesfarmers. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has recommended CSL and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

2 ASX shares tipped to grow up to 122% in the next 12 months

These companies could be on the cusp of something big.

Read more »

Thumbs down Facebook icon over dark screen.
Broker Notes

Why these 5 ASX shares were downgraded by brokers this week

Market analysts explain why they've downgraded these ASX stocks.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Domino's Pizza, Super Retail, PLS shares

Let's check out some new ratings on ASX shares today.

Read more »